Therefore, our research findings, indicating that knockout of CHEK2 selectively weakens the relevant biological functions of HCC cells with TP53 mutations, may provide a potential target for TP53-mutant HCC cells. The gene discussed is TP53; the disease is hepatocellular carcinoma.